ストックスクリーナーアプリを入手
20.11
0.69%
-0.14
前日終値:
$20.25
開ける：
$20.14
24時間の取引高:
565.87K
Relative Volume:
0.38
時価総額：
$2.29B
収益：
-
当期純損益:
$-804.34M
株価収益率:
-2.1371
EPS:
-9.41
ネットキャッシュフロー:
$-531.06M
1週間 パフォーマンス:
-11.99%
1か月 パフォーマンス:
+7.71%
6か月 パフォーマンス:
-62.39%
1年 パフォーマンス:
-51.38%
1日の値動き範囲:
$20.01
$21.43
1週間の範囲:
$18.75
$23.37
52週間の値動き範囲:
$15.79
$55.70
Biohaven Ltd Stock (BHVN) Company Profile
BHVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
20.10 | 2.29B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.64 | 128.25B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
535.22 | 63.70B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
550.82 | 39.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.87 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.77 | 27.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-09-16 | 開始されました | Jefferies | Buy |
| 2024-09-04 | 開始されました | Bernstein | Outperform |
| 2024-07-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-16 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-02-06 | 開始されました | UBS | Buy |
| 2023-12-22 | 開始されました | H.C. Wainwright | Buy |
| 2023-12-08 | 開始されました | Robert W. Baird | Outperform |
| 2023-01-24 | 開始されました | SVB Securities | Outperform |
| 2023-01-04 | 開始されました | JP Morgan | Overweight |
| 2022-12-02 | 開始されました | BTIG Research | Buy |
| 2022-10-26 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | 開始されました | Piper Sandler | Overweight |
| 2022-08-19 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-05-11 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-08-10 | ダウングレード | UBS | Buy → Neutral |
| 2021-08-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-03-11 | 開始されました | UBS | Buy |
| 2020-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-17 | 開始されました | Cowen | Outperform |
| 2020-02-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2019-11-22 | 開始されました | Wedbush | Outperform |
| 2019-06-25 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-05-06 | 開始されました | Goldman | Buy |
| 2019-04-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | 繰り返されました | Needham | Buy |
| 2018-07-03 | 繰り返されました | Needham | Buy |
| 2018-07-02 | 繰り返されました | Needham | Buy |
| 2018-04-05 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2018-02-22 | 繰り返されました | Canaccord Genuity | Buy |
| 2017-12-15 | 開始されました | Canaccord Genuity | Buy |
| 2017-10-03 | 繰り返されました | Needham | Buy |
すべてを表示
Biohaven Ltd (BHVN) 最新ニュース
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités - GlobeNewswire Inc.
Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts - msn.com
Biohaven Ltd. Shareholders Approve Key Proposals at Meeting - TipRanks
Biohaven directors re-elected, EY appointed as auditors - Investing.com
Biohaven directors re-elected, EY appointed as auditors By Investing.com - Investing.com UK
UBS Adjusts Biohaven Price Target to $40 From $65, Maintains Buy Rating - marketscreener.com
Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict (NYSE:BHVN) - Seeking Alpha
Raymond James Financial Inc. Buys Shares of 37,033 Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Announces Positive Data from its Exploratory Electroencephalogram (EEG) Biomarker Study of BHV-7000, Completion of Once-Daily Formulation Development, and Plan to Initiate Phase 3 Pivotal Studies - Seeking Alpha
Finance Watch: Biohaven Gains Up To $600m In Fresh Capital - insights.citeline.com
An Intrinsic Calculation For Biohaven Ltd. (NYSE:BHVN) Suggests It's 47% Undervalued - simplywall.st
19,352 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Renaissance Technologies LLC - Defense World
Oberland Capital’s $600 Million Investment in Biohaven - Global Legal Chronicle
Biohaven Ltd [BHVN] Director makes an insider purchase of 32,700 shares worth 1.0 million. - knoxdaily.com
Biohaven (BHVN) Projected to Post Earnings on Thursday - Defense World
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Where are the Opportunities in (BHVN) - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd.’s Strategic Expansion and Financial Strength Bolster Buy Rating - TipRanks
Are Smart Investors Making the Right Decision? Biohaven Ltd (BHVN) - Sete News
BHVN’s Market Whiplash: -41.79% YTD Decline, -23.42% Plunge in 30 Days - investchronicle.com
Biohaven secures $600m financing as it awaits FDA prodrug decision - Yahoo
Biohaven (NYSE:BHVN) Given New $57.00 Price Target at Robert W. Baird - Defense World
Biohaven (BHVN) Secures Up to $600M Investment from Oberland Cap - GuruFocus
Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize
Biohaven secures up to $600 million from Oberland Capital By Investing.com - Investing.com Nigeria
Biohaven secures up to $600 million from Oberland Capital - Investing.com Australia
BHVN’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
Nvidia, Sabre, Biohaven - TradingView
Why BioHaven Stock Is Soaring Today - Mitrade
A Guide To The Risks Of Investing In Biohaven Ltd (BHVN) - knoxdaily.com
Biohaven Ltd. Receives Buy Rating Amid Strategic EU Resubmission and Positive FDA Outlook - TipRanks
Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland - Benzinga
Biohaven to receive investment of up to $600M by Oberland Capital - TipRanks
Biohaven announces investment of up to $600M - Hartford Business Journal
Financial Analysis: Biohaven Ltd (BHVN)’s Ratios Unveil Key Insights - DWinneX
Biohaven Announces Investment by Oberland Capital - Contract Pharma
Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Biohaven Ltd. Secures $600M Investment from Oberland Capital - TipRanks
Biohaven Announces Investment Up To $600 Mln By Oberland Capital - marketscreener.com
Why Biohaven Ltd. Shares Are Tumbling - TipRanks
Biohaven Announces Investment up to $600 Million by Oberland Capital - GuruFocus
Biohaven Signs Deal for Investment of up to $600 Million by Oberland; Shares up Pre-Bell - marketscreener.com
Biohaven (BHVN) Price Target Cut by Baird Amid Regulatory Developments | BHVN Stock News - GuruFocus
Biohaven (BHVN) Price Target Cut by Baird Amid Regulatory Develo - GuruFocus
Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider
Biohaven Lands Massive $600M Backing to Advance First-Ever Treatment for Rare Genetic Disease - Stock Titan
Biohaven (NYSE:BHVN) Upgraded at William Blair - Defense World
Biohaven (BHVN) Faces Market Setback After EMA Withdrawal - GuruFocus
Wells Fargo & Company MN Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven share price undervaluing pipeline potential, says RBC Capital - Yahoo Finance
Biohaven Ltd (BHVN) 財務データ
収益
当期純利益
現金流量
EPS
2.11%
0.83%
大文字化:
|
ボリューム (24 時間):